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Introduction
Necrotizing fasciitis is a rare soft tissue infection, pri-
marily involving the superficial fascia and commonly
resulting in extensive involvement of the surrounding
tissues.1–3 It is generally believed that a continuous
supply of oxygen to the necrotized tissue through the
microcirculation is vital for healing and for protection
against infection.4 One of the possible ways of improv-
ing tissue oxygenation is hyperbaric oxygen (HBO).4 It
has been proven that HBO promotes angiogenesis and
wound healing, kills certain anaerobes, prevents growth
of bacteria such as Pseudomonas, prevents production
of clostridial alpha-toxin, restores neutrophil-mediated
bacterial killing in previously hypoxic tissues, and re-
duces leukocyte adhesion in reperfusion injury, pre-
venting release of proteases and free radicals, which
cause vasoconstriction and cellular damage.4
Based on experimental clinical observations, most
of the national hyperbaric medicine societies have rec-
ommended the initiation of HBO therapy for wound
healing and for minimizing the infectious process for
the treatment of necrotizing soft tissue infection. But
there are few reports on the use of HBO in the field of
obstetrics. Here, we report our experience with HBO
therapy to treat the complication of necrotizing fasciitis
after Cesarean section in a postpartum diabetes mellitus
gravida.
Case Report
Our patient was a 25-year-old, gravida 1, para 1, wom-
an with a history of type 1 diabetes mellitus since the age
of 18, mild fatty liver and obesity. On physical exami-
nation, her fasting blood sugar level was 235 mg/dL
and her postprandial sugar level was 336 mg/dL. He-
moglobin A1c was 12.7%, and ketone bodies were
found in her blood. The patient had a history of failing
to take oral hypoglycemic agents and was consequently
given insulin therapy of around 48U/day for treatment
of type 1 diabetes.
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When she became pregnant, a uterine myoma meas-
uring 42 × 31 × 37 mm in size was found in her anterior
uterine wall during routine prenatal check-up. During
the pregnancy, her insulin was increased to a dosage
of 68 U/day at 29+6 gestational weeks. The pregnancy
course was complicated with an episode of preterm
labor at 31+1 gestational weeks, which was successfully
treated with magnesium sulfate for tocolytic therapy.
The patient then went into labor at 39+6 gestational
weeks, and underwent Cesarean section due to pro-
longed labor associated with non-reassuring fetal status
of both smooth baseline and fetal tachycardia.
Following Cesarean section, the patient experienced
moderate pain at the incision site and moderate-grade
fever (38.2°C) associated with erythematous change
with purulent bloody discharge at the wound site on the
4th postoperative day (Figure 1). The white blood cell
count was 10,500/mm3, and C-reactive protein level
was 1.07 mg/dL (reference range, 0–0.5 mg/dL). An
ultrasound scan of the lower abdomen revealed edema-
tous change of the incision wound and a fluid collection
of 4 mm in depth over the rectus fascia was measured
(Figure 2). The diagnosis of subcutaneous necrotizing
fasciitis was made.5
The fluid collection was aspirated under sonar guid-
ance and the culture was positive for penicillin-resistant
Staphylococcus aureus.6 The patient was then given glyco-
peptide (teicoplanin) and extended-spectrum penicillin
(Tazocin) according to culture sensitivity. A respira-
tory therapy consultant was called, and following that
consultant’s recommendation, we obtained Doppler
scans of the lower limbs, which were normal, and
measured the transcutaneous oxygen tension (TcPo2)
at the upper portion of the Pfannestiel incision, finding
it to be < 40 mmHg.7
The patient received HBO in 1 90-minute daily ses-
sion of 100% oxygen breathing in a multiplace hyper-
baric chamber (Comex Pro, Comex, Marseille, France)
pressurized at 2.5 ATA (absolute atmosphere air) on
the 6th postoperative day. This regimen lasted 5 days 
a week for 2 consecutive weeks, in accordance with
Méchine et al.8 The HBO sessions included a period
of air compression in air for 15 minutes followed by 3
30-minute breathing periods, at a pressure of oxygen
inhalated (Fio2) = 1, separated by 5-minute intervals
of air breathing (Fio2 = 0.21) and then a decompres-
sion period of 15 minutes.7 HBO therapy was then
given for a total of 7 days.
After HBO therapy, the condition of the surgical
wound improved dramatically. The patient’s body tem-
perature returned to normal on the 3rd post-therapeutic
day, and the edematous and erythematous appearance
of the wound site completely resolved on the last ther-
apeutic day. The 1-month follow-up of the surgical
wound after completion of HBO therapy revealed no
adverse changes at the wound site, and it had healed
uneventfully. No wound debridement or open wound
drainage was needed.
Discussion
Necrotizing fasciitis is a rare, often fulminant, rapidly
progressive infectious process that primarily involves
the fascia and subcutaneous tissue. The wide range of
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Figure 2. Depiction of the 2-dimensional ultrasound of the incisional wound complicated with acute fasciitis. There was fluid collection
of 4 mm in depth above the rectus fascia.
Figure 1. Edematous, erythematous change of the skin, associ-
ated with necrotizing fasciitis, along the Pfannestiel incision before
hyperbaric oxygen therapy began.
therapeutic strategies for such wounds reflects the
various pathologies that may cause tissue breakdown,
including poor blood supply resulting in inadequate
oxygenation of the wound bed. HBO therapy has been
suggested to improve oxygen supply to wounds and
therefore improve their healing.9 Patients with necro-
tizing fasciitis usually present with the triad of exqui-
site pain, swelling and fever. Tenderness, erythema, and
warm skin are commonly the only signs of early dis-
ease.9 Distinction between uncomplicated infectious
cellulitis or fasciitis, and necrotizing fasciitis is impor-
tant. This condition is difficult to recognize in the early
phase when it is often confused with cellulitis. Ultra-
sonography of the lesions demonstrated distorted,
thickened fascia with fluid accumulation.3 The ultra-
sonographic diagnosis of necrotizing fasciitis is based
on the criterion of diffuse thickening of the subcuta-
neous tissue accompanied by a layer of fluid accumu-
lation of > 4 mm in depth.3 Ultrasonography is also
used as a guide for aspiration of pus. The choice of anti-
biotic therapy is made on the results of culture. In our
case, the fluid accumulation was aspirated, but it had
disappeared after HBO therapy. Surgical debridement
and drainage was avoided. This case study provides
evidence that HBO therapy increased the healing rate
of necrotizing fasciitis in Pfannestiel incisional wound
in diabetes mellitus gravida. It suggests the possibility
of shortening hospitalization stay by more than 3 weeks
in such patients.7
Oxygen is an essential component of wound heal-
ing, and the wound’s ability to heal can be directly
linked to the level of tissue oxygenation.10 Oxygen is
used for protein synthesis, cell replication, hydroxyl-
ation of collagen, exportation of collagen out of the
fibroblast cell, and neoepithelialization.10 The effective-
ness of wound repair is directly related to oxygen con-
centration.10 Angiogenesis at the edges of the wound
site is driven by the existing oxygen gradient8 between
the oxygen-poor area in the center of the wound and the
oxygen-rich area at the periphery of the wound.10 The
oxygen-poor, lactate-rich environment in the center
promotes macrophages to produce angiogenesis factors
until capillary ingrowth is complete, while the periph-
ery of the wound supplies the oxygen necessary to
support the angiogenesis process. Furthermore, the
leukocyte’s ability to kill bacteria is based in part on its
ability to produce free radicals, which is oxygen gradient-
dependent.10 This gradient also affects the leukocyte’s
ability to clear bacteria from the wound site.10
Systemic HBO further increases tissue oxygenation.
The treatment consists of placing the patient in a pres-
sure chamber set at a pressure greater than 1 atmos-
phere and adjusting the surface breathing mixtures to
100% oxygen.6 Each gram of hemoglobin carries
1.34 mL of bound oxygen, while inhaled air only adds
0.3 mL of dissolved oxygen per 100 mL of blood. This
means that someone with a hemoglobin level of 15 g/
dL who is breathing normal air carries 20.1 mL of
oxygen (15 × 1.34) via hemoglobin. S/he also carries
0.33mL of dissolved oxygen in the surrounding plasma
for a total of 20.4 mL per 100 mL. HBO further in-
creases the amount of dissolved oxygen, so that each
additional atmosphere of pure oxygen adds 2.2 mL of
dissolved oxygen per 100 mL of blood (2.2 vol%).10
Measurement of the partial oxygen pressure of the
tissue (PtO2) can be accomplished by introducing a
small oxygen sensor into the tissue. Subcutaneous tis-
sue is the first tissue to suffer from oxygen deprivation
and the last to be normalized, for which reasons this
tissue level is the optimal place for monitoring general
tissue perfusion. Clinically, measurement of the blood
saturation (pulse oximetry) is used routinely. This meth-
od, however, primarily reflects the oxygen conditions
in the blood, and it only has value in situations where all
factors that influence PtO2 are functioning optimally.11
What are the criteria that determine who will benefit
from HBO therapy? Several studies measured whether
patients’ tissue oxygen level during HBO was predictive
of response.12 One study of 20 patients with chronic
arterial insufficiency ulcer and diabetic ulcer reported
that wound healing was achieved in all patients who
were able to achieve a distal transcutaneous tissue oxy-
gen level of at least 100 mmHg during HBO therapy.11
The selection of patients for HBO should exclude
those with contraindications, including emphysema,
proliferating retinopathy and claustrophobia.10 There
are risks associated with HBO therapy that are similar
to diving disorders. Pressure changes can cause a
“squeeze” or barotrauma in the tissues surrounding
trapped air inside the body, such as the lungs, behind
the eardrum, inside paranasal sinuses, or trapped under-
neath dental fillings. Breathing high-pressure oxygen
for long periods can cause oxygen toxicity. Temporary
blurred vision can be caused by swelling of the lens,
which usually resolves in 2–4 weeks.9 Examination of
the adverse events reported for all forms of HBO ther-
apy revealed that oxygen toxicity in the form of seizures
was observed in up to about 10% of patients in several
studies.12 One seizure-related death occurred in a
“severely toxemic” patient who died 2 hours after an
uncontrolled seizure.12 A patient with pneumothorax
was 1 among several deaths reported in a case series of
30 patients.12 The pneumothorax was not reported to
be the immediate cause of death in this patient. The
need to provide emergency care during HBO treat-
ment suggests that multiplace chambers may provide
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a safer treatment modality, although this has not been
demonstrated.12
In Taiwan, HBO therapy is not recognized by the
Bureau of National Health Insurance. However, de-
bridement and dressing changes for necrotizing fasciitis
prolonged a 4-week admission for a diabetic gravida.
The cost of the entire admission for the traditional ther-
apy was more than NT$56,000. Since an HBO ther-
apy session of 7 days costs NT$14,000, there would
be a significant potential cost saving, amounting to
NT$42,000, by using adjunctive HBO therapy.
In conclusion, the results of this case report show
that HBO has the potential to enhance healing of nec-
rotizing fasciitis in diabetes mellitus gravida and is cost-
effective. A large multicenter trial is needed to confirm
the long-term, large-scale results.13
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